Pharvaris NV (NASDAQ: PHVS) released topline data from the CHAPTER-1 Phase 2 study meeting its primary endpoint, with deucrictibant demonstrating statistically significant and clinically meaningful results as an oral preventative treatment for people living with
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday.
The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell, dropping, 0.05% to 4,565.09.
Alabama cannabis regulator is facing yet another lawsuit following its third attempt on Friday to allocate much sought-after medical marijuana business permits.
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer
Key Takeaways:
Bitdeer said it was picked as a preferred cloud services provider for artificial intelligence cloud services powered by an Nvidia chip
Cryptocurrency mining machine maker Canaan is looking to create a separate unit for its business making chips for AI applications
By Warren Yang
IGM Biosciences Inc (NASDAQ: IGMS) said it will focus on two strategic areas: treating colorectal cancer using IgM death receptor 5 (DR5) agonist antibodies and treating autoimmune diseases using IgM T
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28% to 14,270.30. The S&P 500 also rose, gaining, 0.32% to 4,581.88.